United Kingdom Immuno Chemistry Market Outlook to 2024

Published : Nov-2017

No. of Pages : 116

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Immuno Chemistry Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 9
3 Immuno Chemistry Market, United Kingdom 13
3.1 Immuno Chemistry Market, United Kingdom, Revenue ($m), 2010-2017 13
3.2 Immuno Chemistry Market, United Kingdom, Revenue ($m), 2017-2024 15
3.2.1 Complement Deficiency Tests Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 17
3.2.2 Diabetes Assays Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 19
3.2.3 Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 21
3.2.4 Endocrinology Tests Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 23
3.2.5 IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 25
3.2.6 Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 27
3.2.7 Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 29
3.2.8 Vitamins Tests Market, United Kingdom, Revenue ($m), by Segment, 2010-2017 31
3.2.9 Complement Deficiency Tests Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 33
3.2.10 Diabetes Assays Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 35
3.2.11 Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 37
3.2.12 Endocrinology Tests Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 39
3.2.13 IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 41
3.2.14 Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 43
3.2.15 Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 45
3.2.16 Vitamins Tests Market, United Kingdom, Revenue ($m), by Segment, 2017-2024 47
3.3 Immuno Chemistry Market, United Kingdom, Volume (Units), 2010-2017 49
3.4 Immuno Chemistry Market, United Kingdom, Volume (Units), 2017-2024 51
3.4.1 Complement Deficiency Tests Market, United Kingdom, Volume (Units), by Segment, 2010-2017 53
3.4.2 Diabetes Assays Market, United Kingdom, Volume (Units), by Segment, 2010-2017 55
3.4.3 Disease Specific Immunochemistry Market, United Kingdom, Volume (Units), by Segment, 2010-2017 57
3.4.4 Endocrinology Tests Market, United Kingdom, Volume (Units), by Segment, 2010-2017 59
3.4.5 IgE Allergy Blood Tests Market, United Kingdom, Volume (Units), by Segment, 2010-2017 61
3.4.6 Immunochemistry Analyzers Market, United Kingdom, Volume (Units), by Segment, 2010-2017 63
3.4.7 Immunochemistry Rapid Tests & POC Market, United Kingdom, Volume (Units), by Segment, 2010-2017 65
3.4.8 Vitamins Tests Market, United Kingdom, Volume (Units), by Segment, 2010-2017 67
3.4.9 Complement Deficiency Tests Market, United Kingdom, Volume (Units), by Segment, 2017-2024 69
3.4.10 Diabetes Assays Market, United Kingdom, Volume (Units), by Segment, 2017-2024 71
3.4.11 Disease Specific Immunochemistry Market, United Kingdom, Volume (Units), by Segment, 2017-2024 73
3.4.12 Endocrinology Tests Market, United Kingdom, Volume (Units), by Segment, 2017-2024 75
3.4.13 IgE Allergy Blood Tests Market, United Kingdom, Volume (Units), by Segment, 2017-2024 77
3.4.14 Immunochemistry Analyzers Market, United Kingdom, Volume (Units), by Segment, 2017-2024 79
3.4.15 Immunochemistry Rapid Tests & POC Market, United Kingdom, Volume (Units), by Segment, 2017-2024 81
3.4.16 Vitamins Tests Market, United Kingdom, Volume (Units), by Segment, 2017-2024 83
3.5 Immuno Chemistry Market, United Kingdom, Average Price ($), 2010-2024 85
3.6 Immuno Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), 2017 89
3.7 Immuno Chemistry Market, United Kingdom, Company Share by Revenue ($m), 2017 90
4 Overview of Key Companies in United Kingdom, Immuno Chemistry Market 92
4.1 F. Hoffmann-La Roche Ltd 92
4.1.1 Company Overview 92
4.2 Siemens Healthcare GmbH 92
4.2.1 Company Overview 92
4.3 Abbott Laboratories 92
4.3.1 Company Overview 92
4.4 Beckman Coulter Inc 92
4.4.1 Company Overview 92
4.5 Thermo Fisher Scientific Inc 93
4.5.1 Company Overview 93
4.6 DiaSorin S.p.A 93
4.6.1 Company Overview 93
4.7 Diazyme Laboratories Inc 93
4.7.1 Company Overview 93
4.8 Diagnostic Automation/ Cortez Diagnostics Inc 93
4.8.1 Company Overview 93
5 Immuno Chemistry Market Pipeline Products 94
6 Recent Developments 97
6.1 Corporate Communications 97
6.1.1 Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 97
6.1.2 Oct 24, 2017: Fiona Marshall to lead AgPlus Diagnostics 97
6.1.3 Aug 10, 2017: Launch of IDS-iSYS Free Testosterone assay - New Assay In The IDS Fertility Portfolio 97
6.1.4 Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 98
6.1.5 Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 98
6.1.6 Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 98
6.1.7 Nov 15, 2016: Ignyta Announces EAP Designation and CE Marking for its Trailblaze Pharos Clinical Trial Assay 99
6.1.8 Nov 14, 2016: Dr. Michael Mullen Presents Multi-Center Clinical Data of More Than 100 NobleStitch EL Patients at Major U.S. Cardiac Congress 100
6.2 Financial Announcements 101
6.2.1 Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 101
6.2.2 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 102
6.2.3 Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 102
6.2.4 May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results 103
6.2.5 Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 104
6.3 Legal And Regulatory 104
6.3.1 Jul 03, 2017: Premaitha Health Litigation Update 104
6.3.2 Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 105
6.3.3 Apr 11, 2017: NovaBiotics Quality Management System Achieves ISO 9001 certification 105
6.3.4 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 105
6.4 Other Significant Developments 106
6.4.1 Sep 21, 2017: MedaPhor: Multi-system contract awarded at Mohawk College in Canada 106
6.4.2 Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 106
6.4.3 Jan 24, 2017: Biofortuna expands its immunoassay development and manufacturing services 106
6.5 Product News 107
6.5.1 Feb 20, 2017: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma 107
6.6 Strategy And Business Planning 107
6.6.1 Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 107
6.6.2 Dec 20, 2016: Singulex Opens European Office and Advances IVD System Evaluation 108
7 Appendix 110
7.1 Research Methodology 111
7.1.1 Coverage 111
7.1.2 Secondary Research 111
7.1.3 Primary Research 112
7.1.4 Market Modeling and Forecasting 113
7.1.5 Company Share Analysis 114
7.1.6 Distribution Share Analysis 115
7.1.7 Benchmarking 115
7.2 GlobalData Consulting 115
7.3 Contact Us 116
7.4 Disclaimer 116

1.1 List of Tables
Table 1: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 14
Table 2: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 16
Table 3: Complement Deficiency Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 18
Table 4: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 5: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 6: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 7: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 8: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 9: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 10: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 11: Complement Deficiency Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 12: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 13: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 14: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 15: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 16: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 17: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 18: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 19: Immuno Chemistry Market, United Kingdom, Volume (Units), Historic, 2010-2017 50
Table 20: Immuno Chemistry Market, United Kingdom, Volume (Units), Forecast, 2017-2024 52
Table 21: Complement Deficiency Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 54
Table 22: Diabetes Assays Market, United Kingdom, Volume (Units), Historic, 2010-2017 56
Table 23: Disease Specific Immunochemistry Market, United Kingdom, Volume (Units), Historic, 2010-2017 58
Table 24: Endocrinology Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 60
Table 25: IgE Allergy Blood Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 62
Table 26: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), Historic, 2010-2017 64
Table 27: Immunochemistry Rapid Tests & POC Market, United Kingdom, Volume (Units), Historic, 2010-2017 66
Table 28: Vitamins Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 68
Table 29: Complement Deficiency Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 70
Table 30: Diabetes Assays Market, United Kingdom, Volume (Units), Forecast, 2017-2024 72
Table 31: Disease Specific Immunochemistry Market, United Kingdom, Volume (Units), Forecast, 2017-2024 74
Table 32: Endocrinology Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 76
Table 33: IgE Allergy Blood Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 78
Table 34: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), Forecast, 2017-2024 80
Table 35: Immunochemistry Rapid Tests & POC Market, United Kingdom, Volume (Units), Forecast, 2017-2024 82
Table 36: Vitamins Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 84
Table 37: Immuno Chemistry Market, United Kingdom, Average Price ($) Historic, 2010-2017 85
Table 38: Immuno Chemistry Market, United Kingdom, Average Price ($), Forecast, 2017-2024 87
Table 39: Immuno Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2017 89
Table 40: Immuno Chemistry Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2017 91
Table 41: Immuno Chemistry Market Pipeline Products 94
Table 42: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 113

1.2 List of Figures
Figure 1: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 13
Figure 2: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 15
Figure 3: Complement Deficiency Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 17
Figure 4: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 19
Figure 5: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 6: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 7: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 8: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 9: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 10: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 11: Complement Deficiency Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Figure 12: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Figure 13: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Figure 14: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Figure 15: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 16: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 17: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 18: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 19: Immuno Chemistry Market, United Kingdom, Volume (Units), Historic, 2010-2017 49
Figure 20: Immuno Chemistry Market, United Kingdom, Volume (Units), Forecast, 2017-2024 51
Figure 21: Complement Deficiency Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 53
Figure 22: Diabetes Assays Market, United Kingdom, Volume (Units), Historic, 2010-2017 55
Figure 23: Disease Specific Immunochemistry Market, United Kingdom, Volume (Units), Historic, 2010-2017 57
Figure 24: Endocrinology Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 59
Figure 25: IgE Allergy Blood Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 61
Figure 26: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), Historic, 2010-2017 63
Figure 27: Immunochemistry Rapid Tests & POC Market, United Kingdom, Volume (Units), Historic, 2010-2017 65
Figure 28: Vitamins Tests Market, United Kingdom, Volume (Units), Historic, 2010-2017 67
Figure 29: Complement Deficiency Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 69
Figure 30: Diabetes Assays Market, United Kingdom, Volume (Units), Forecast, 2017-2024 71
Figure 31: Disease Specific Immunochemistry Market, United Kingdom, Volume (Units), Forecast, 2017-2024 73
Figure 32: Endocrinology Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 75
Figure 33: IgE Allergy Blood Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 77
Figure 34: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), Forecast, 2017-2024 79
Figure 35: Immunochemistry Rapid Tests & POC Market, United Kingdom, Volume (Units), Forecast, 2017-2024 81
Figure 36: Vitamins Tests Market, United Kingdom, Volume (Units), Forecast, 2017-2024 83
Figure 37: Immuno Chemistry Market, United Kingdom, Company Share (%) 2017 90

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

United Kingdom Immuno Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model